This inventor holds 1 USPTO granted patent. Top assignee: Sterling Drug Inc.. Active years: 1994.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1994
Title: The Innovative Contributions of James B Rake
Introduction
James B Rake is a notable inventor based in Halfmoon, NY (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of methods to combat malignant cells. His work has implications for cancer treatment and showcases the importance of innovation in medical science.
Latest Patents
James B Rake holds a patent for a method of inhibiting mammalian topoisomerase II and malignant cell growth. This patent describes a method that utilizes a specific compound, (S)-3-methyl-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzoxazine or -benzothiazine, to inhibit the growth of malignant cells in mammals. The patent outlines the chemical structure and potential applications of this compound, which could lead to advancements in cancer therapies. He has 1 patent to his name.
Career Highlights
James B Rake has had a distinguished career, working with Sterling Drug Inc., where he has focused on pharmaceutical innovations. His research and development efforts have contributed to the advancement of medical treatments, particularly in oncology.
Collaborations
Throughout his career, James has collaborated with notable colleagues, including Mark P Wentland and the late George Y Lesher. These collaborations have fostered a productive environment for innovation and have led to significant advancements in their respective fields.
Conclusion
James B Rake's contributions to the field of pharmaceuticals highlight the critical role of inventors in advancing medical science. His innovative methods for inhibiting malignant cell growth demonstrate the potential for new treatments in cancer therapy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
